Cortivazol: Difference between revisions
No edit summary |
No edit summary |
||
Line 52: | Line 52: | ||
| StdInChIKey = RKHQGWMMUURILY-UHRZLXHJSA-N | | StdInChIKey = RKHQGWMMUURILY-UHRZLXHJSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Cortivazol''' is a high-affinity [[agonist]] [[ligand (biochemistry)|ligand]] for the [[glucocorticoid receptor]] and consequently is classified as a [[glucocorticoid]].<ref name="pmid4029081">{{cite journal | author = Schlechte JA, Simons SS, Lewis DA, Thompson EB | title = [3H]cortivazol: a unique high affinity ligand for the glucocorticoid receptor | journal = Endocrinology | volume = 117 | issue = 4 | pages = 1355–62 |date=October 1985 | pmid = 4029081 | doi = 10.1210/endo-117-4-1355| url = }}</ref> | '''Cortivazol''' is a high-affinity [[agonist]] [[ligand (biochemistry)|ligand]] for the [[glucocorticoid receptor]] and consequently is classified as a [[glucocorticoid]].<ref name="pmid4029081">{{cite journal | author = Schlechte JA, Simons SS, Lewis DA, Thompson EB | title = [3H]cortivazol: a unique high affinity ligand for the glucocorticoid receptor | journal = Endocrinology | volume = 117 | issue = 4 | pages = 1355–62 |date=October 1985 | pmid = 4029081 | doi = 10.1210/endo-117-4-1355| url = }}</ref> | ||
Line 63: | Line 67: | ||
{{MeshName|Cortivazol}} | {{MeshName|Cortivazol}} | ||
[[Category:Glucocorticoids]] | [[Category:Glucocorticoids]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 19:19, 8 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C32H38N2O5 |
Molar mass | 530.655 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Cortivazol |
Articles |
---|
Most recent articles on Cortivazol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cortivazol at Clinical Trials.gov Clinical Trials on Cortivazol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cortivazol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cortivazol Discussion groups on Cortivazol Patient Handouts on Cortivazol Directions to Hospitals Treating Cortivazol Risk calculators and risk factors for Cortivazol
|
Healthcare Provider Resources |
Causes & Risk Factors for Cortivazol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cortivazol is a high-affinity agonist ligand for the glucocorticoid receptor and consequently is classified as a glucocorticoid.[1]
It is sometimes abbreviated "CVZ".[2]
References
- ↑ Schlechte JA, Simons SS, Lewis DA, Thompson EB (October 1985). "[3H]cortivazol: a unique high affinity ligand for the glucocorticoid receptor". Endocrinology. 117 (4): 1355–62. doi:10.1210/endo-117-4-1355. PMID 4029081.
- ↑ Yoshikawa N, Yamamoto K, Shimizu N, Yamada S, Morimoto C, Tanaka H (May 2005). "The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor". Mol. Endocrinol. 19 (5): 1110–24. doi:10.1210/me.2004-0264. PMID 15677712.
External links
Cortivazol at the US National Library of Medicine Medical Subject Headings (MeSH)
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Glucocorticoids
- Drug